Clinical Trial Update: Decitabine Followed by Mitoxantrone Hydrochloride, Etoposide, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating decitabine followed by mitoxantrone, etoposide, and cytarabine in adults with relapsed/refractory acute myeloid leukemia or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Decitabine (Decitabine)
• Etoposide (Etoposide)
• Mitoxantrone hydrochloride (mitoxantrone)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-01-12